DWTX

Dogwood Therapeutics, Inc.

Insider trading activity for Dogwood Therapeutics, Inc., straight from SEC Form 4 filings. Net figures below count open-market buys and sales only — grants, option exercises and tax withholding are excluded because they are compensation, not decisions to trade.

Past 3 months

net buying

Bought(0 · 0 insiders): $0
Sold(0 · 0 insiders): $0

Past 6 months

net buying

Bought(0 · 0 insiders): $0
Sold(0 · 0 insiders): $0

Past 12 months

net buying

Bought(0 · 0 insiders): $0
Sold(0 · 0 insiders): $0

Transaction history

The 32 most recent Form 4 transactions.

Open in screener →

Insider transactions, newest first: date, security, transaction type, size and a link to the filing each row came from.
Date	Insider	Role	Type	Shares	Price	Value	Δ Own	Filing
Jun 16	Keefer David R	Director	AGRANT◆	16,800	—	—	—	Open the original filing on SEC.gov
Jun 16	Whitley Richard James	Director	AGRANT◆	16,800	—	—	—	Open the original filing on SEC.gov
Jun 16	Thomas John C	Director	AGRANT◆	16,800	—	—	—	Open the original filing on SEC.gov
Jun 16	De La Rosa Abel	Director	AGRANT◆	16,800	—	—	—	Open the original filing on SEC.gov
Mar 5	Duncan Gregory Scott	Chief Executive Officer	AGRANT◆	330,000	—	—	—	Open the original filing on SEC.gov
Mar 5	Gendreau Roger Michael	Chief Medical Officer	AGRANT◆	82,500	—	—	—	Open the original filing on SEC.gov
Mar 5	Grosswald Ralph	SVP of Operations	AGRANT◆	82,500	—	—	—	Open the original filing on SEC.gov
Mar 5	Walsh Angela	Chief Financial Officer	AGRANT◆	82,500	—	—	—	Open the original filing on SEC.gov
Dec 4, 2025	Duncan Gregory Scott	Chief Executive Officer	AGRANT◆	460,000	—	—	—	Open the original filing on SEC.gov
Dec 4, 2025	Gendreau Roger Michael	Chief Medical Officer	AGRANT◆	150,000	—	—	—	Open the original filing on SEC.gov
Dec 4, 2025	Grosswald Ralph	SVP of Operations	AGRANT◆	150,000	—	—	—	Open the original filing on SEC.gov
Dec 4, 2025	Walsh Angela	Chief Financial Officer	AGRANT◆	150,000	—	—	—	Open the original filing on SEC.gov
Nov 21, 2025	Sealbond Ltd	Director, 10% Owner	CCONV◆	284.26	—	—	—	Open the original filing on SEC.gov
Nov 21, 2025	Sealbond Ltd	Director, 10% Owner	CCONV◆	2,161.09	—	—	—	Open the original filing on SEC.gov
Nov 21, 2025	Sealbond Ltd	Director, 10% Owner	CCONV	2.8M	—	—	—	Open the original filing on SEC.gov
Nov 21, 2025	Sealbond Ltd	Director, 10% Owner	CCONV	21.6M	—	—	+10,224%	Open the original filing on SEC.gov
Jun 27, 2025	Gendreau Roger Michael	Chief Medical Officer	AGRANT◆	12,075	—	—	—	Open the original filing on SEC.gov
Jun 27, 2025	Whitley Richard James	Director	AGRANT◆	2,362	—	—	—	Open the original filing on SEC.gov
Jun 27, 2025	Grosswald Ralph	SVP of Operations	AGRANT◆	12,075	—	—	—	Open the original filing on SEC.gov
Jun 27, 2025	Thomas John C	Director	AGRANT◆	2,362	—	—	—	Open the original filing on SEC.gov
Jun 27, 2025	Duncan Gregory Scott	Chief Executive Officer	AGRANT◆	40,000	—	—	—	Open the original filing on SEC.gov
Jun 27, 2025	Keefer David R	Director	AGRANT◆	2,362	—	—	—	Open the original filing on SEC.gov
Jun 27, 2025	Walsh Angela	Chief Financial Officer	AGRANT◆	12,075	—	—	—	Open the original filing on SEC.gov
Jun 27, 2025	De La Rosa Abel	Director	AGRANT◆	2,362	—	—	—	Open the original filing on SEC.gov
Jun 18, 2025	Whitley Richard James	Director	AGRANT◆	210	—	—	—	Open the original filing on SEC.gov
Jun 18, 2025	Whitley Richard James	Director	AGRANT◆	210	—	—	—	Open the original filing on SEC.gov
Jun 18, 2025	Keefer David R	Director	AGRANT◆	210	—	—	—	Open the original filing on SEC.gov
Jun 18, 2025	Keefer David R	Director	AGRANT◆	210	—	—	—	Open the original filing on SEC.gov
Jun 18, 2025	Thomas John C	Director	AGRANT◆	210	—	—	—	Open the original filing on SEC.gov
Jun 18, 2025	Thomas John C	Director	AGRANT◆	210	—	—	—	Open the original filing on SEC.gov
Jun 18, 2025	De La Rosa Abel	Director	AGRANT◆	210	—	—	—	Open the original filing on SEC.gov
Jun 18, 2025	De La Rosa Abel	Director	AGRANT◆	210	—	—	—	Open the original filing on SEC.gov

AGRANT◆—

Keefer David R · DirectorJun 16

16,800 sh

AGRANT◆—

Whitley Richard James · DirectorJun 16

16,800 sh

AGRANT◆—

Thomas John C · DirectorJun 16

16,800 sh

AGRANT◆—

De La Rosa Abel · DirectorJun 16

16,800 sh

AGRANT◆—

Duncan Gregory Scott · Chief Executive…Mar 5

330,000 sh

AGRANT◆—

Gendreau Roger Michael · Chief Medical…Mar 5

82,500 sh

AGRANT◆—

Grosswald Ralph · SVP of OperationsMar 5

82,500 sh

AGRANT◆—

Walsh Angela · Chief Financial…Mar 5

82,500 sh

AGRANT◆—

Duncan Gregory Scott · Chief Executive…Dec 4, 2025

460,000 sh

AGRANT◆—

Gendreau Roger Michael · Chief Medical…Dec 4, 2025

150,000 sh

AGRANT◆—

Grosswald Ralph · SVP of OperationsDec 4, 2025

150,000 sh

AGRANT◆—

Walsh Angela · Chief Financial…Dec 4, 2025

150,000 sh

CCONV◆—

Sealbond Ltd · Director, 10%…Nov 21, 2025

284.26 sh

CCONV◆—

Sealbond Ltd · Director, 10%…Nov 21, 2025

2,161.09 sh

CCONV—

Sealbond Ltd · Director, 10%…Nov 21, 2025

2.8M sh

CCONV—

Sealbond Ltd · Director, 10%…Nov 21, 2025

21.6M sh · +10,224% own

AGRANT◆—

Gendreau Roger Michael · Chief Medical…Jun 27, 2025

12,075 sh

AGRANT◆—

Whitley Richard James · DirectorJun 27, 2025

2,362 sh

AGRANT◆—

Grosswald Ralph · SVP of OperationsJun 27, 2025

12,075 sh

AGRANT◆—

Thomas John C · DirectorJun 27, 2025

2,362 sh

AGRANT◆—

Duncan Gregory Scott · Chief Executive…Jun 27, 2025

40,000 sh

AGRANT◆—

Keefer David R · DirectorJun 27, 2025

2,362 sh

AGRANT◆—

Walsh Angela · Chief Financial…Jun 27, 2025

12,075 sh

AGRANT◆—

De La Rosa Abel · DirectorJun 27, 2025

2,362 sh

AGRANT◆—

Whitley Richard James · DirectorJun 18, 2025

210 sh

AGRANT◆—

Whitley Richard James · DirectorJun 18, 2025

210 sh

AGRANT◆—

Keefer David R · DirectorJun 18, 2025

210 sh

AGRANT◆—

Keefer David R · DirectorJun 18, 2025

210 sh

AGRANT◆—

Thomas John C · DirectorJun 18, 2025

210 sh

AGRANT◆—

Thomas John C · DirectorJun 18, 2025

210 sh

AGRANT◆—

De La Rosa Abel · DirectorJun 18, 2025

210 sh

AGRANT◆—

De La Rosa Abel · DirectorJun 18, 2025

210 sh

Filing record

How quickly insiders here report their trades. Section 16 allows two business days from the transaction.

All 25 filings we hold were filed within the two-business-day deadline.

Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings

Insiders at this company

Everyone who has filed a Form 4 for this issuer.

More biotech & pharma companies

Other issuers in the same industry with insider filings on record.

Whole sector →